Liver resection in multimodal concepts improves survival of metastatic melanoma: a single-centre case-matched control study.
Anticancer Res
; 34(11): 6633-9, 2014 Nov.
Article
in En
| MEDLINE
| ID: mdl-25368268
ABSTRACT
BACKGROUND/AIM:
The aim of the present study was to define prognostic factors and to evaluate liver resection as an additive tool in metastatic melanoma. PATIENTS ANDMETHODS:
In a case-control study, 32 patients with hepatic melanoma metastasis were analyzed between 1998-2012. Sixteen patients who underwent liver resection (6 patients with multimodal therapy) were matched to 16 patients scheduled for non-surgical approaches. Univariate and multivariate analyses were performed.RESULTS:
Following primary resection and liver resection, respectively, survival was better for patients who underwent surgery in addition to multimodal therapy with 219 and 28 months, when compared to patients scheduled for non-surgical approaches with 64 (p=0.04) and 8 months (p=0.6). Following primary resection, primary tumor site, metastatic time <70 months, combination of multimodal therapy and surgery were of prognostic value (p<0.05).CONCLUSION:
Liver resection should be considered a suitable additive tool in multimodal therapy of resectable metastatic melanoma.Key words
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Skin Neoplasms
/
Antineoplastic Combined Chemotherapy Protocols
/
Hepatectomy
/
Liver Neoplasms
/
Melanoma
Type of study:
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Anticancer Res
Year:
2014
Document type:
Article
Affiliation country:
Germany